We are live on
!
Find out more
US Bancorp Portfolio holdings
AUM
$82.4B
1-Year Est. Return
19.69%
This Fund
S&P 500
This Quarter
Est. Return
+8.01%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$39.1B
AUM Growth
+$2.42B
(+6.6%)
Cap. Flow
-$248M
Cap. Flow
% of AUM
-0.63%
Top 10 Holdings %
Top 10 Hldgs %
22.64%
Holding
3,845
New
218
Increased
1,110
Reduced
1,483
Closed
148
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell Mid-Cap ETF
IWR
|
+$45.6M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$40.7M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$38.8M |
| 4 |
iShares S&P 500 Value ETF
IVE
|
+$35.5M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$34.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$80.2M |
| 2 |
Copart
CPRT
|
+$55.9M |
| 3 |
US Bancorp
USB
|
+$47.8M |
| 4 |
IBDK
iShares iBonds Dec 2019 Term Corporate ETF
IBDK
|
+$25.8M |
| 5 |
iShares Floating Rate Bond ETF
FLOT
|
+$17.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.27% |
| 2 | Financials | 10.78% |
| 3 | Industrials | 9.91% |
| 4 | Healthcare | 9.19% |
| 5 | Consumer Staples | 6.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Chefs' Warehouse
CHEF
$3.87B
| $2.29M | 0.01% |
60,054
+1,092
| +2% | +$39.7K |
|
727
Paylocity
PCTY
$6.71B
| $2.28M | 0.01% |
18,893
+199
| +1% | +$21.8K |
|
728
Kimco Realty
KIM
$17.6B
| $2.27M | 0.01% |
109,598
-604
| -0.5% | -$12.7K |
|
729
Nutrien
NTR
$32.7B
| $2.27M | 0.01% |
47,338
-3,797
| -7% | -$183K |
|
|
PRO
730
DELISTED
PROS Holdings
PRO
| $2.27M | 0.01% |
37,844
-1,402
| -4% | -$80.9K |
|
731
Zillow
Z
$7.04B
| $2.27M | 0.01% |
49,352
-11,449
| -19% | -$427K |
|
732
WEX
WEX
$6.11B
| $2.26M | 0.01% |
10,801
+7,442
| +222% | +$1.49M |
|
733
State Street SPDR Dow Jones Global Real Estate ETF
RWO
$1.32B
| $2.26M | 0.01% |
43,881
+24
| +0.1% | +$1.25K |
|
734
First Trust Technology AlphaDEX Fund
FXL
$2.47B
| $2.26M | 0.01% |
31,103
+286
| +0.9% | +$19.6K |
|
735
Huntington Bancshares
HBAN
$35.1B
| $2.25M | 0.01% |
149,545
-20,947
| -12% | -$307K |
|
736
Corpay
CPAY
$24.2B
| $2.25M | 0.01% |
7,828
+1,415
| +22% | +$417K |
|
737
Euronet Worldwide
EEFT
$3.02B
| $2.25M | 0.01% |
14,271
+3,731
| +35% | +$563K |
|
738
Sensata Technologies
ST
$6.65B
| $2.24M | 0.01% |
41,597
+2,446
| +6% | +$126K |
|
739
Spire
SR
$4.92B
| $2.24M | 0.01% |
26,882
+1,856
| +7% | +$152K |
|
740
Ulta Beauty
ULTA
$20.4B
| $2.24M | 0.01% |
8,836
-7,763
| -47% | -$1.9M |
|
741
W.P. Carey
WPC
$17.1B
| $2.22M | 0.01% |
28,343
-1,294
| -4% | -$108K |
|
742
Jazz Pharmaceuticals
JAZZ
$15.9B
| $2.21M | 0.01% |
14,840
-2,505
| -14% | -$341K |
|
|
HES
743
DELISTED
Hess
HES
| $2.21M | 0.01% |
33,072
+1,575
| +5% | +$103K |
|
744
iShares Biotechnology ETF
IBB
$9.31B
| $2.2M | 0.01% |
18,226
+1,696
| +10% | +$189K |
|
745
Littelfuse
LFUS
$10.2B
| $2.19M | 0.01% |
11,436
-437
| -4% | -$80.2K |
|
746
Take-Two Interactive
TTWO
$43B
| $2.17M | 0.01% |
17,768
-1,091
| -6% | -$133K |
|
747
DTE Energy
DTE
$31.1B
| $2.17M | 0.01% |
19,648
-2,715
| -12% | -$293K |
|
|
AMED
748
DELISTED
Amedisys
AMED
| $2.17M | 0.01% |
12,969
+11
| +0.1% | +$1.64K |
|
749
Associated Banc-Corp
ASB
$5.81B
| $2.15M | 0.01% |
97,610
+4,667
| +5% | +$98.5K |
|
|
LHCG
750
DELISTED
LHC Group LLC
LHCG
| $2.14M | 0.01% |
15,530
-1,148
| -7% | -$143K |
|
Similar funds
US Bancorp's Q4 2019 Portfolio in Review
As of Q4 2019, US Bancorp held 3,845 positions worth $39.1B, up 6.6% from $36.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
US Bancorp's Q4 2019 filing shows 218 new, 1,110 increased, 1,483 reduced and 148 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M. The largest sale was Celgene Corp, an estimated $80.2M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.
- US Bancorp's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M.
- US Bancorp added most to iShares Russell Mid-Cap ETF in Q4 2019, an estimated $45.6M increase.
- US Bancorp's biggest Q4 2019 reduction was Copart, cutting an estimated $55.9M.
- US Bancorp fully exited Celgene Corp in Q4 2019, selling an estimated $80.2M.
- US Bancorp's ten largest holdings make up 23% of its $39.1B portfolio in Q4 2019.
- US Bancorp opened 218 new positions and closed 148 in Q4 2019.
- US Bancorp's portfolio value rose 6.6% quarter-over-quarter to $39.1B.
Based on US Bancorp's 13F filing for Q4 2019, filed 4 Feb 2020.